[Progress in the area of drug development. Part 9].
D000818:Animals; D000890:Anti-Infective Agents / Q000494:pharmacology; D000927:Anticonvulsants / Q000494:pharmacology; D000932:Antiemetics / Q000494:pharmacology; D000978:Antiparkinson Agents / Q000494:pharmacology; D002490:Central Nervous System / Q000187:drug effects; D000697:Central Nervous System Stimulants / Q000494:pharmacology; D003278:Contraceptives, Oral, Hormonal / Q000494:pharmacology; D003280:Contraceptives, Oral, Synthetic / Q000494:pharmacology; D004202:Disinfectants / Q000494:pharmacology; D004358:Drug Therapy; D004967:Estrogens / Q000494:pharmacology; D005938:Glucocorticoids / Q000494:pharmacology; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D006728:Hormones / Q000494:pharmacology; D006801:Humans; D010525:Peripheral Nerves / Q000187:drug effects; D004364:Pharmaceutical Preparations; D011453:Prostaglandins / Q000494:pharmacology; D012702:Serotonin Antagonists; D014149:Tranquilizing Agents / Q000494:pharmacology
D000890:Anti-Infective Agents; D000927:Anticonvulsants; D000932:Antiemetics; D000978:Antiparkinson Agents; D000697:Central Nervous System Stimulants; D003278:Contraceptives, Oral, Hormonal; D003280:Contraceptives, Oral, Synthetic; D004202:Disinfectants; D004967:Estrogens; D005938:Glucocorticoids; D006634:Histamine H1 Antagonists; D006728:Hormones; D004364:Pharmaceutical Preparations; D011453:Prostaglandins; D012702:Serotonin Antagonists; D014149:Tranquilizing Agents
Fortschritte auf dem Gebiet der Arzneimittelentwicklung. Teil 9